Clinical biologic pathophysiologies of women's sexual dysfunction

Journal of Sexual Medicine

Volumn 2, Issue 1, 2005, Pages 4-25

  Nappi, Rossella ^a   Salonia, Andrea ^b   Traish, Abdulmaged M ^c   van Lunsen, Rik H W ^d   Vardi, Yoram ^e   Kodiglu, Ates ^f   Goldstein, Irwin ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e RAMBAM MEDICAL CENTER   (Israel)

^f ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Pathophysiology of arousal; Pathophysiology of desire

Indexed keywords

ANDROGEN; ANTIDEPRESSANT AGENT; CONJUGATED ESTROGEN; ESTROGEN; FLUOXETINE; METHYLTESTOSTERONE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE; TESTOSTERONE; TESTOSTERONE PROPIONATE; TESTOSTERONE UNDECANOATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTERY BLOOD FLOW; AUTONOMIC NERVOUS SYSTEM; BLOOD VESSEL INJURY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; CONSULTATION; CYSTECTOMY; DEPRESSION; DIABETES MELLITUS; DISEASE EXACERBATION; DRUG ACTIVITY; ENDOCRINE SYSTEM; EVIDENCE BASED MEDICINE; FEMALE; FEMALE GENITAL SYSTEM; FEMALE SEXUAL DYSFUNCTION; HUMAN; HYSTERECTOMY; INTERNATIONAL COOPERATION; INTERPERSONAL COMMUNICATION; LIBIDO DISORDER; MEDICAL EXPERT; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL SPECIALIST; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INJURY; NEUROPATHY; ORGASM DISORDER; PATHOPHYSIOLOGY; PELVIS SURGERY; PERFUSION PRESSURE; PRIORITY JOURNAL; REVIEW; SEXUAL AROUSAL; SEXUAL FUNCTION; SEXUALITY; SOMATOSENSORY SYSTEM; SYSTEMATIC REVIEW; UROLOGY;

EID: 16344367081     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2005.20102.x     Document Type: Article

References (249)

1. Semmers J, Wagner G. Estrogen deprivation and vaginal function in postmenopausal women. JAMA 1982;248:445-8.
2. Rosen R, Bachmann G, Leiblum S, Goldstein I. Androgen insufficiency in women: The Princeton Conference. Fertil Steril 2002;77:S1-99.
3. Nappi RE, Brundu B, Ferdeghini F, Sampaolo P, Abbiati I, Salonia A, Montorsi F, Polatti F. Biological determinants of female sexual dysfunction (FSD) - I: Endocrine, reproductive, uro-genital and surgical factors. Gynecol Endocrinol (in press).
4. Braunstein GD. Androgen insufficiency in women: Summary of critical issues. Fertil Steril 2002;77: S94-9.
5. Davis SR. When to suspect androgen deficiency other than at menopause. Fertil Steril 2002;77: S68-71.
6. Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990;75:26S-35S.
7. Bachmann GA. The hyperandrogenic woman: Pathophysiologic overview. Fertil Steril 2002;77: S72-6.
8. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-43.
9. Sarrel PM. Androgen deficiency: Menopause and estrogen-related factors. Fertil Steril 2002;77:S63-7.
10. Sarrel PM. Effects of hormone replacement therapy on sexual psychophysiology and behaviour in postmenopause. J Womens Health Gend Based Med 2000;9:S25-32.
11. Campbell S. Double blind psychometric studies on the effects of natural estrogens on postmenopausal women. In: Campbell S, editor. The management of the menopause and post-menopausal years. Lancaster, PA: MTP Press; 1976:149-58.
12. Utian WH. The true clinical features of postmenopause and oophorectomy and their response to oestrogen therapy. S Afr Med J 1972;46:732-7.
13. Coope J, Thmpson JM, Poller L. Effect of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting. Br Med J 1975;4: 139-43.
14. Fedor-Freybergh P. The influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand 1977;64:1-91.
15. Dennerstein L, Burrows GD, Wood C, Hyman G. Hormones and sexuality: Effect of estrogen and progestogen. Obstet Gynecol 1980;56:316-22.
16. Nathorst-Boos J, Wiklund I, Mattsson LA, Sandin K, von Schoultz B. Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women. Acta Obstet Gynecol Scand 1993;72:656-60.
17. Geist SH, Salmon UJ. Androgen therapy in gynecology. JAMA 1941;117:2207-13.
18. Greenblatt RB, Barfiled WE, Garner JF. Evaluation of an estrogen, androgen and estrogen-androgen combination, and placebo in the treatment of the menopause. J Clin Endocrinol Metab 1950;10:1616-17.
19. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987; 49:397-409.
20. Burger HG, Hailes J, Menelaus M, Nelson J, Hudson B, Balazs N. The management of persistent menopausal symptoms with oestradiol-testosterone implants: Clinical, lipid and hormonal results. Maturitas 1984;6:351-8.
21. Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227-36.
22. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med 1998;43:847-56.
23. Floter A, Nathorst-Boos J, Carlstrom K, von Schoultz B. Addition of testosterone to estrogen replacement therapy in oophorectomized women: Effects on sexuality and well-being. Climacteric 2002;5:357-65.
24. Shifren J, Braunstein G, Siman J, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-8.
25. Slag MF, Morley JE, Elson MK, Trence DL, Nelson CJ, Nelson AE, Kinlaw WB, Beyer HS, Nuttall FQ, Shafer RB. Impotence in medical clinic outpatients. JAMA 1983;249:1736-40.
26. Spark RF. Neuroendocrinology and impotence. Ann Intern Med 1983;98:103-5.
27. Braunstein GD. Endocrine causes of impotence. Optimistic outlook for restoration of potency. Postgrad Med 1983;74:207-17.
28. Wortsman J, Rosner W, Dufau ML. Abnormal testicular function in men with primary hypothyroidism. Am J Med 1987;82:207-12.
29. Baskin HJ. Endocrinologic evaluation of impotence. South Med J 1989;82:446-9.
30. Arlt W, Hove U, Muller B, Reincke M, Berweiler U, Schwab F, Allolio B. Frequent and frequently overlooked: Treatment-induced endocrine dysfunction in adult long-term survivors of primary brain tumors. Neurology 1997;49:498-506.
31. Biller BM, Luciano A, Crosignani PG, Molitch M, Olive D, Rebar R, Sanfilippo J, Webster J, Zacur H. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med 1999;44:1075-84.
32. Kruger THC, Haake P, Hartmann U, Schedlowski M, Exton MS. Orgasm-induced prolactin secretion: Feedback control of sexual drive? Neurosci Behav Rev 2002;26:31-44.
33. Sauder SE, Freger M, Case GD, Kelch RP, Marshall JC. Abnormal patterns of pulsitile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: Responses to bromocriptine. J Clin Endocrinol Metab 1984;59:941-8.
34. Carani C, Granata ARM, Faustini Fustini M, Marrama P. Prolactin and testosterone: Their role in male sexual function. Int J Androl 1996;19:48-54.
35. Koppelman MCS, Parry BL, Hamilton JA, Alagna SW, Loriaux DL. Effect of bromocriptine on affect and libido in hyperprolactinemia. Am J Psychiatry 1987;144:1037-41.
36. Hulter B, Lundberg PO. Sexual function in women with hypothalamo-pituitary disorders. Arch Sex Behav 1994;23:171-83.
37. Lundberg PO, Hulter B. Sexual dysfunction in patients with hypothalamo-pituitary disorders. Exp Clin Endocrinol 1991;98:81-8.
38. Mastrogiacomo I, De Besi L, Serafini E, Zussa S, Zucchetta P, Romagnoli GF, Saporiti E, Dean P, Ronco C, Adami A. Hyperprolactinemia and sexual disturbances among uremic women on hemodialysis. Nephron 1984;37:195-9.
39. Weizman R, Weizman A, Levi J, Gura V, Zevin D, Maoz B, Wijsenbeek H, Ben David M. Sexual dysfunction associated with hyperprolactinemia in males and females undergoing hemodialysis. Psychosom Med 1983;45:259-69.
40. Schiavi RC, Segraves RT. The biology of sexual function. Psych Clin North Am 1995;18:7-23.
41. Breier AL, Malhotra AK, Su T-P, Pinals DA, Elman I, Adler CM, Lfargue T, Clifton A, Pickar D. Clozapine and risperidone in chronic schizophrenia: Effects on symptoms, parkinsonian side effects and neuroendocrine response. Am J Psychiatry 1999;156:294-8.
42. Hummer M, Kemmler G, Kurz M, Kurzthaler I, Oberbauer H, Fleischhacker WW. Sexual disturbance during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry 1999;156:294-8.
43. Dickson RA, Seeman MV, Corenblum B. Hormonal side effects in women: Typical versus atypical antipsychotic treatment. J Clin Psychiatry 2000;61(3 suppl):10-15.
44. Maguire GA. Prolactin elevation with antipsychotic medications: Mechanisms of action and clinical consequences. J Clin Psychiatry 2002;63 (4 suppl):56-62.
45. Wieck A, Haddad PM. Antipsychotic-induced hyperprolactinaemia in women: Pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry 2003;182:199-204.
46. Goodnick PJ, Rodriguez L, Santana O. Antipsychotics: Impact on prolactin levels. Expert Opin Pharmacother 2002;3:1381-91.
47. Compton MT, Miller AH. Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacol Bull 2002;36:143-64.
48. Compton MT, Miller AH. Sexual side effects associated with conventional and atypical antipsychotics. Psychopharmacol Bull 2001;35:89-108.
49. Cowen PJ, Sargent PA. Changes in plasma prolactin during SSRI treatment: Evidence for a delayed increase in 5-HAT neuro-transmission. J Psychopharmacol 1997;11:345-8.
50. Meltzer H, Bastani B, Jayathilake K, Maes M. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder. Neuropsychopharmacology 1997;17: 1-11.
51. Shen WW, Hsu JH. Female sexual side effects associated with selective serotonin reuptake inhibitors: A descriptive clinical study of 33 patients. Int J Psychiatr Med 1995;25:239-48.
52. Montejo-Gonzalez AL, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De La Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E. SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997;23:176-94.
53. Rosen RC, Lane RM, Menza M. Effects of SSRI on sexual function: A critical review. J Clin Psychopharmacol 1999;19:67-85.
54. Zaslansky R, Yarnitsky D. Clinical applications of quantitative sensory testing. J Neurol Sci 1998, 153:215-38.
55. Vardi Y, Gruenwald I, Sprecher E, Gertman I, Yarnitsky D. Normative values for female genital sensation. Urology 2000;56:1035-40.
56. Dyck PJ, Karnes J, O'Brien P, Zimmerman IR. Detection thresholds of cutaneous sensation in humans. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo, JF, editors. Peripheral neuropathy, Vol. 1. Philadelphia: WB Saunders Co.; 1993: 706-28.
57. Dyck PJ, Kennedy WR, Kesserwani H, Melanson M, Ochoa J, Shy M, Stevens JC, Suarez GAO, Brien PC. Limitations of quantitative sensory testing when patients are biased toward a bad outcome. Neurology 1998;50:1213-16.
58. Yarnitsky D, Sprecher E, Zaslansky R, Hemli JA. Heat pain thresholds: Normative data and repeatability. Pain 1995;60:329-32.
59. Bartlett G, Stewart JD, Tamblyn R, Abrahamowicz M. Normal distributions of thermal and vibration sensory thresholds. Muscle Nerve 1998;21:367-74.
60. Vardi Y, Yarnitsky D, Gertman I, Sprecher E, Gruenwald I. Diagnosis of organic sexual dysfunction in neuropathic females by sensory measurement of the vagina and clitoris. Int J Impot Res 2001;13(1 suppl):57.
61. Munarriz R, Talakoub L, Somekh NN, Lehrfeld T, Chudnovsky A, Flaherty E, Goldstein I. Characteristics of female patients with sexual dysfunction who also had a history of blunt perineal trauma. Sex Marital Ther 2002;28(1 suppl):175-9.
62. Sax DS, Berman JR, Goldstein I. Female neurogenic sexual dysfunction secondary to clitoral neuropathy. Sex Marital Ther 2001;27:599-60.
63. Sipski ML, Alexander CJ, Rosen RC. Orgasm in women with spinal cord injuries: A laboratory-based assessment. Arch Phys Med Rehabil 1995; 76:1097-102.
64. Sipski ML, Alexander CJ, Rosen R. Sexual arousal and orgasm in women: Effect of spinal cord injury. Ann Neurol 2001;49:35-44.
65. Whipple B, Gerdes CA, Komisaruk BR. Sexual response to self stimulation in women with complete spinal cord injury. J Sex Res 1996;33:231-40.
66. Burns AS, Rivas DA, Ditunno JF. The management of neurogenic bladder and sexual dysfunction after spinal cord injury. Spine 2001;26:S129-36.
67. Berard EJJ. The sexuality of spinal cord injured women: Physiology and pathophysiology. A review. Paraplegia 1989;27:99-112.
68. Westgren N, Hultling C, Levi R, Seiger A, Westgren M. Sexuality in women with traumatic spinal cord injury. Acta Obstet Gynecol Scand 1997;76:977-83.
69. Whipple B, Komisaruk BR. Sexuality and women with complete spinal cord injury. Spinal Cord 1997;35:136-8.
70. Benevento BT, Sipski ML. Neurogenic bladder, neurogenic bowel, and sexual dysfunction in people with spinal cord injury. Phys Ther 2002;82: 601-12.
71. Sipski ML, Alexander CJ, Rosen RC. Physiologic parameters associated with psychogenic sexual arousal in women with complete spinal cord injuries. Arch Phys Med Rehabil 1995;76:811-18.
72. Sipski ML, Rosen RC, Alexander CJ. Physiological parameters associated with the performance of a distracting task and genital self-stimulation in women with complete spinal cord injuries. Arch Phys Med Rehabil 1996;77:419-24.
73. Geiger RC. Neurophysiology of sexual response in spinal cord injury. Sex Disabil 1979;2:257-66.
74. Charlifue SW, Gerhart KA, Menter RR, Whiteneck GG, Manley MS. Sexual issues of women with spinal cord injuries. Paraplegia 1992;30:192-9.
75. Sipski ML, Alexander CJ. Sexual activities, response and satisfaction in women pre- and post-spinal cord injury. Arch Phys Med Rehabil 1993; 74:1025-9.
76. Sipski ML. Spinal cord injury and sexual function: An educational model. In: Sipski ML, Alexander CJ, editors. Sexual function in people with disability and chronic illness. Gaithersburg, MD: Aspen Publishers Inc.; 1997:149-76.
77. Harrison J, Glass CA, Owens RG, Soni BM. Factors associated with sexual functioning in women following spinal cord injury. Paraplegia 1995;33: 687-92.
78. Sherfey MJ. The nature and evolution of female sexuality. New York: Random House; 1966.
79. Mould DE. Neuromuscular aspects of women's orgasms. J Sex Res 1980;16:193-201.
80. Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol 1999;161: 743-57.
81. DasGupta R, Fowler CJ. Bladder, bowel and sexual dysfunction in multiple sclerosis. Management strategies. Drugs 2003;63:153-66.
82. DasGupta R, Fowler CJ. Sexual and urological dysfunction in multiple sclerosis: Better understanding and improved therapies. Curr Opin Neurol 2002;15:271-8.
83. Lillius H, Valtonen C, Wilkstrom J. Sexual problems in patients suffering from multiple sclerosis. J Chron Dis 1976;19:643-7.
84. Laumann E, Palik A, Rosen R. Sexual dysfunction in the united states: Prevalence and predictors. JAMA 1999;281:537-44.
85. Villeroy ML, Kraft GH. Sexual dysfunction in multiple sclerosis. Arch Phys Med Rehabil 1984; 65:125-8.
86. Zorzon M, Zivadinov R, Bosco A, Monti Bragadin L, Moretti R, Bonfigli L, Morassi P, Iona LG, Cazzato G. Sexual dysfunction in multiple sclerosis: A case-control study. I. Frequency and comparison of groups. Mult Scler 1999;5:418-27.
87. Lundberg PO. Sexual dysfunction in female patients with multiple sclerosis. Int Rehabil Med 1981;3:32-4.
88. Minderhoud JM, Leemhuis JG, Kremer J, Laban E, Smits PM. Sexual disturbances arising from multiple sclerosis. Acta Neurol Scand 1984;70: 299-306.
89. Mattson D, Petrie M, Srivastava DK, McDermott M. Multiple sclerosis. Sexual dysfunction and its response to medications. Arch Neurol 1995;52: 862-8.
90. Stenager E, Stenager EN, Jensen K. Sexual function in multiple sclerosis. Ital J Neurol Sci 1996;17: 67-9.
91. Hulter BM, Lundberg PO. Sexual function in women with advanced multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;59:83-6.
92. Zivadinov R, Zorzon M, Bosco A, Monti Bragadin L, Moretti R, Bonfigli L, Iona LG, Cazzato G. Sexual dysfunction in multiple sclerosis: A case-control study. II. Correlation analysis. Mult Scler 1999;5:428-31.
93. Folstein M, Folstein S, McHugh P. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
94. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
95. Betts C, D'Mellow M, Fowler C. Erectile dysfunction in multiple sclerosis: Associated neurological and neurophysiological deficits, and treatment of the condition. Brain 1994;117:1303-10.
96. Nortvedt M, Riise T, Myhr K, Landtblom AM, Bakke A, Nyland HI. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler 2001;7:231-5.
97. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.
98. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50.
99. Zorzon M, Zivadinov R, Monti Bragadin L, Moretti R, De Masi R, Nasuelli D, Cazzato G. Sexual dysfunction in multiple sclerosis: A 2-year follow-up study. J Neurol Sci 2001;187:1-5.
100. Hennessey A, Robertson NP, Swinger R, Compston DAS. Urinary, faecal and sexual dysfunction in patients with multiple sclerosis. J Neurol 1999;246:1027-32.
101. Yang CC, Bowen JR, Kraft GH, Uchio EM, Kromm BG. Cortical evoked potentials of the dorsal nerve of the clitoris and female sexual dysfunction in multiple sclerosis. J Urol 2000;164: 2010-13.
102. Gruenwald I, Miller A, Gertman I, Sprecher E, Yarnitsky D, Vardi Y. Sexual dysfunction in females with multiple sclerosis diagnosed by sensory testing of the genitalia. Eur Urol 2001;39(5 suppl): 412.
103. Wincze JP, Albert A, Bansal S. Sexual arousal in diabetic females; physiological and self-report measures. Arch Sex Behav 1993;22:587-601.
104. Jensen SB. Sexual dysfunction in insulin-treated diabetics: A six-year follow-up study of 101 patients. Arch Sex Behav 1986;15:271-83.
105. Schreiner-Engel P, Schiavi RC, Vietorisz D, Smith H. The differential impact of diabetes type on female sexuality. J Psychosom Res 1987;31:23-33.
106. Prather RC. Sexual dysfunction in the diabetes female: A review. Arch Sex Behav 1988;17:277-84.
107. Zemel P. Sexual dysfunction in the diabetic patient with hypertension. Am J Cardiol 1988;61:27H-33H.
108. Campbell LV, Redelman MJ, Borkman M, McLay JG, Chisholm DJ. Factors in sexual dysfunction in diabetic female volunteer subjects. Med J Aust 1989;151:550-2.
109. Arshag D, Mooradian MD, Greiff V. Sexuality in older women. Arch Intern Med 1990;150:1033-8.
110. Leedom L, Feldman M, Procci W, Zeidler A. Symptoms of sexual dysfunction and depression in diabetic women. J Diabetes Complications 1991;5: 38-41.
111. Jensen SB. Sexuality and chronic illness: Biopsychosocial approach. Semin Neurol 1992;12:135-40.
112. Dunning P. Sexuality and women with diabetes. Patient Educ Couns 1993;21:5-14.
113. LeMone P. The physical effects of diabetes on sexuality in women. Diabetes Educ 1996;22:361-6.
114. Jensen SB. Sexual relationships in couples with a diabetic partner. J Sex Marital Ther 1985;11:259-70.
115. Enzlin P, Demyttenaere K, Vanderschueren D, Mathieu C. Diabetes and female sexuality: A review of 25 years research. Diabetic Med 1998;15: 809-15.
116. Schiel R, Muller UA. Prevalence of sexual disorders in a selection-free diabetic population (JEVIN). Diabetes Res Clin Pract 1999;44:115-21.
117. Enzlin P, Mathieu C, Van den Bruel A, Bosteels J, Vanderschueren D, Demyttenaere K. Sexual dysfunction in women with type 1 diabetes. Diabetes Care 2002;25:672-7.
118. Erol B, Tefekli A, Ozbey I, Salman F, Dincag N, Kafioglu A, Tellaloglu S. Sexual dysfunction in type II diabetic females: A comparative study. J Sex Marital Ther 2002;28(1 suppl):55-62.
119. Salonia A, Lanzi R, Gatti E, Nappi RE, Calori G, Rigatti P, Montorsi F. Sexual dysfunction in Italian diabetic women. Int J Impot Res 2002;14:S27.
120. Havenga K, DeRuiter MC, Enker WA, Welvaart K. Anatomical basis of autonomic nerve-preserving total mesorectal excision for rectal cancer. Br J Surg 1996;83:384-8.
121. Huber FT, Stepan R, Zimmermann F, Fink U, Molls M, Siewert JR. Locally advanced irresectable rectal cancer: Resection and intraoperative radiotherapy using the flab method combined with preoperative or postoperative radiochemotherapy. Dis Colon Rectum 1996;39:774-9.
122. Farouk R, Nelson H, Gunderson L. Aggressive treatment for locally advanced irresectable rectal cancer. Br J Surg 1997;84:741-9.
123. Banerjee AK. Sexual dysfunction after surgery for rectal cancer. Lancet 1999;353:1900-2.
124. Willett CG, Shellito PC, Tepper JE, Eliseio R, Convery K, Wood WC. Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma. J Clin Oncol 1991;9:843-9.
125. Willett CG, Shellito PC, Tepper JE, Eliseio R, Convery K, Wood WC. Intraoperative electron beam radiation therapy for recurrent locally advanced rectal and rectosigmoid carcinoma. Cancer 1991;67:1504-8.
126. Hashiguchi Y, Sekine T, Sakamoto H, Tanaka Y, Kazumoto T, Kato S, Sakura M, Fuse Y, Suda Y. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum 1999;42:886-95.
127. Mannaerts GHH, Schijven MP, Hendrikx A, Martijin H, Rutten HJT, Wiggers T. Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer. EJSO 2001;27: 265-72.
128. Kim HK, Jessup JM, Beard CJ, Bornstein B, Cady B, Stone MD, Bleday R, Bothe A Jr, Steele G Jr, Busse PM. Locally advanced rectal carcinoma: Pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 1997;38:777-83.
129. Saito N, Sarashina H, Nunomura M, Koda K, Takiguchi N, Nakajima N. Clinical evaluation of nerve-sparing surgery combined with preoperative radiotherapy in advanced rectal cancer patients. Am J Surg 1998;175:277-82.
130. Hojo K, Vernava AM, Sugihara K, Katumata K. Preservation of urine voiding and sexual function after rectal cancer surgery. Dis Colon Rectum 1991;34:532-9.
131. Moriya Y, Sugihara K, Akatsu T, Fujita S. Patterns of recurrence after nerve sparing surgery for rectal adenocarcinoma with special reference to locoregional recurrence. Dis Colon Rectum 1995;38: 1162-8.
132. Enker WE. Potency, cure, and local control in the operative treatment for rectal cancer. Arch Surg 1992;127:1396-402.
133. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479-82.
134. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457-60.
135. Nesbakken A, Nygaard K, Bull-Njaa T, Cralsen E, Eri LM. Bladder and sexual dysfunction after mesorectal excision for rectal cancer. Br J Surg 2000;87:206-10.
136. Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T, Sawada T. Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 2001;44:1274-80.
137. Cohen AM. Radical surgery for rectal cancer: Why we fail and rationale for current clinical trials of adjuvant therapy. Surg Oncol Clin N Am 2000;9: 741-7.
138. Havenga K, Maas CP, DeRuiter MC, Welvaart K, Trimbos JB. Avoiding long-term disturbance to bladder and sexual function in pelvic surgery, particularly with rectal cancer. Semin Surg Oncol 2000;18:235-43.
139. Maas CP, Moriya Y, Steup WH, Kiebert GM, Kranenbarg WM, van de Velde CJ. Radical and nerve-preserving surgery for rectal cancer in The Netherlands: A prospective study on morbidity and functional outcome. Br J Surg 1998;85:92-7.
140. Enker WE, Havenga K, Polyak T, Thaler H, Cranor M. Abdominoperineal resection via total mesorectal excision and autonomic nerve preservation for low rectal cancer. World J Surg 1997;21: 715-20.
141. Pocard M, Zinzindohoue F, Haab F, Caplin S, Parc R, Tiret E. A prospective study of sexual and urinary function before and after total mesorectal excision with autonomic nerve preservation for rectal cancer. Surgery 2002;131:368-72.
142. Chorost MI, Weber TK, Lee RJ, Rodriguez-Bigas MA, Petrelli NJ. Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. Am J Surg 2000;179:271-4.
143. Mannaerts GH, Rutten HJ, Martijn H, Hanssens PE, Wiggers T. Effects on functional outcome after IORT-containing multimodality treatment for locally advanced primary and locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys 2002;54:1082-8.
144. Chatwin NA, Ribordy M, Givel JC. Clinical outcomes and quality of life after low anterior resection for rectal cancer. Eur J Surg 2002;168: 297-301.
145. Quah HM, Jayne DG, Eu KW, Seow-Choen F. Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer. Br J Surg 2002;89:1551-6.
146. van Driel MF, Weymar Schultz WC, van de Wiel HB, Hahn DE, Mensink HJ. Female sexual functioning after radical surgical treatment of rectal and bladder cancer. Eur J Surg Oncol 1993;19: 183-7.
147. Ofman US. Preservation of function in genitourinary cancers: Psychosexual and psychosocial issues. Cancer Invest 1995;13:125-31.
148. Marshall FF, Treiger BF. Radical cystectomy (anterior exenteration) in the female patient. Urol Clin North Am 1991;18:765-75.
149. Bjerre BD, Johansen C, Steven K. A questionnaire study of sexological problems following urinary diversion in the female patient. Scand J Urol Nephrol 1997;31:155-60.
150. Nordstrom GM, Nyman CR. Male and female sexual function and activity following ileal conduit urinary diversion. Br J Urol 1992;70:33-9.
151. Hautmann RE, Paiss T, de Petriconi R. The ileal neobladder in women: 9 years of experience with 18 patients. J Urol 1996;155:76-81.
152. Horenblas S, Meinhardt W, Ijzerman W, Moonen LF. Sexuality preserving cystectomy and neobladder: Initial results. J Urol 2001;166:837-40.
153. Dodds DT, Potgieter CR, Turner PJ, Scheepers GPJ. The physical and emotional results of hysterectomy: A review of 162 cases. S Afr Med J 1961; 35:53-4.
154. Craig GA, Jackson P. Sexual life after vaginal hysterectomy. BMJ 1975;3:97.
155. Dennerstein L, Wood C, Burrows GD. Sexual response following hysterectomy and oopherectomy. Obstet Gynecol 1977;49:92-6.
156. Nathorst-Boos J, van Schoultz B. Psychological reactions and sexual life after hysterectomy with and without oophorectomy. Gynecol Obstet Invest 1992;34:971-101.
157. Helstrom L, Lundberg PO, Sorbom D, Backstrom T. Sexuality after hysterectomy: A factor analysis of women's sexual lives before and after subtotal hysterectomy. Obstet Gynecol 1993;81:357-62.
158. Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hysterectomy and sexual function. JAMA 1999;282:1934-41.
159. Carlson KJ. Outcomes of hysterectomy. Clin Obstet Gynecol 1997;40:939-46.
160. Rako S. Testosterone deficiency: A key factor in the increased cardiovascular risk to women following hysterectomy or with natural aging? J Womens Health 1998;7:825-9.
161. Rako S. Testosterone supplemental therapy after hysterectomy with or without concomitant oophorectomy: Estrogen alone is not enough. J Womens Health Gend Based Med 2000;9:917-23.
162. Cutler WB, Genovese-Stone E. Wellness in women after 40 years of age: The role of sex hormones and pheromones. Dis Mon 1998;44: 421-546.
163. Rannestad T, Eikeland OJ, Helland H, Qvarnstrom U. Are the physiologically and psychosocially based symptoms in women suffering from gynecological disorders alleviated by means of hysterectomy? J Womens Health Gend Based Med 2001;10:579-87.
164. Coppen A, Bishop M, Beard RJ, Barnard GJR, Collins WP. Hysterectomy, hormones and behaviour. Lancet 1981;1:126-8.
165. Ewert B, Slangen T, Van Herendael B. Sexuality after laparoscopic-assisted vaginal hysterectomy. J Am Assoc Gynecol Laparosc 1995;3:27-32.
166. Katz A. Sexuality after hysterectomy. J Obstet Gynecol Neonatal Nurs 2002;31:256-62.
167. Lepine LA, Hillis SD, Marchbanks PE, Koonin LM, Morrow B, Kieke BA, Wilcox LS. Hysterectomy surveilance - United States, 1980-1993. MMWR Morb Mortal Wkly Rep 1997;46:1-15.
168. Shifren JL. Androgen deficiency in the oophorectomized woman. Fertil Steril 2002;77(4 suppl):60-2.
169. Mazer NA, Leiblum SR, Rosen RC. The brief index of sexual functioning for women (BISF-W): A new scoring algorithm and comparison of normative and surgically menopausal populations. Menopause 2000;7:350-63.
170. Reynolds PL. Do women with impaired sexual function following oophorectomy benefit from transdermal testosterone at a physiologic dose? J Fam Pract 2000;49:1148.
171. Galyer KT, Conaglen HM, Hare A, Conaglen JV. The effect of gynecological surgery on sexual desire. J Sex Marital Ther 1999;25:81-8.
172. Bellrose SB, Binik YM. Body image and sexuality in oophorectomized women. Arch Sex Behav 1993;38:781-90.
173. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: Identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1986;47:94-100.
174. Kaiser R, Kursche M, Wurz H. Hormone levels in women after hysterectomy. Arch Gynecol Obstet 1989;244:169-73.
175. Oldenhave A, Jaszmann LJB, Everaerd W, Haspels AA. Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age. Am J Obste Gynecol 1993;168:765-71.
176. Hasson HM. Cervical removal at hysterectomy for benign disease: Risks and benefits. J Reprod Med 1993;38:781-90.
177. Kindermann G, Debus-Thiede G. Postoperative urological complications after radical surgery for cervical cancer. Baillieres Clin Obstet Gynaecol 1988;2:933-41.
178. Tong XK, Huo RJ. The anatomical basis and prevention of neurogenic voiding dysfunction following radical hysterectomy. Surg Radiol Anat 1991;13:145-8.
179. Primicero M, Montanino-Oliva M, Casa A, Cirese E. Laparoscopic lymphadenectomy and vaginal radical hysterectomy for the treatment of cervical cancer. J Am Assoc Gynecol Laparosc 1996;3:S40-1.
180. Lee PI, Lee YT, Lee SH, Chang YK. Advantages of total laparoscopic hysterectomy. J Am Assoc Gynecol Laparosc 1996;3:S24-5.
181. Zivkovic F, Tamussino K, Ralph G, Schied G, Auer-Grumbach M. Long-term effects of vaginal dissection on the innervation of the striated urethral sphincter. Obstet Gynecol 1996;87:257-60.
182. Hockel M, Konerding MA, Heussel CP. Liposuction-assisted nerve-sparing extended radical hysterectomy: Oncologic rationale, surgical anatomy, and feasibility study. Am J Obstet Gynecol 1998;178:971-6.
183. Grimes DA. Role of the cervix in sexual response: Evidence for and against. Clin Obstet Gynecol 1999;42:972-8.
184. Weber AM, Walters MD, Schover LR, Church JM, Piedmonte MR. Functional outcomes and satisfaction after abdominal hysterectomy. Am J Obstet Gynecol 1999;181:530-5.
185. Possover M, Stober S, Plaul K, Schneider A. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. Gynecol Oncol 2000;79:154-7.
186. Butler-Manuel SA, Buttery LD, A'Hern RP, Polak JM, Barton DP. Pelvic nerve plexus trauma at radical hysterectomy and simple hysterectomy: The nerve content of the uterine supporting ligaments. Cancer 2000;89:834-41.
187. Kuwabara Y, Suzuki M, Hashimoto M, Furugen Y, Yoshida K, Mitsuhashi N. New method to prevent bladder dysfunction after radical hysterectomy for uterine cervical cancer. J Obstet Gynaecol Res 2000;26:1-8.
188. Yabuki Y, Asamoto A, Hoshiba T, Nishimoto H, Nishikawa Y, Nakajima T. Radical hysterectomy: An anatomic evaluation of parametrial dissection. Gynecol Oncol 2000;77:155-63.
189. Trimbos JB, Maas CP, Deruiter MC, Peters AA, Kenter GG. A nerve-sparing radical hysterectomy: Guidelines and feasibility in Western patients. Int J Gynecol Cancer 2001;11:180-6.
190. Kato T, Murakami G, Yabuki Y. Does the cardinal ligament of the uterus contain a nerve that should be preserved in radical hysterectomy? Anat Sci Int 2002;77:161-8.
191. Murakami G, Yabuki Y, Kato T. A nerve-sparing radical hysterectomy: Guidelines and feasibility in Western patients. Int J Gynecol Cancer 2002;12: 319-21.
192. Querleu D, Narducci F, Poulard V, Lacaze S, Occelli B, Leblanc E, Cosson M. Modified radical vaginal hysterectomy with or without laparoscopic nerve-sparing dissection: A comparative study. Gynecol Oncol 2002;85:154-8.
193. Quinn MJ, Kirk N. Differences in uterine innervation at hysterectomy. Am J Obstet Gynecol 2002;187:1515-9.
194. Butler-Manuel SA, Buttery LD, A'Hern RP, Polak JM, Barton DP. Pelvic nerve plexus trauma at radical and simple hysterectomy: A quantitative study of nerve types in the uterine supporting ligaments. J Soc Gynecol Invest 2002;9:47-56.
195. Kim DH, Lee YS, Lee ES. Alteration of sexual function after classic intrafascial supracervical hysterectomy and total hysterectomy. J Am Assoc Gynecol Laparosc 2003;10:60-4.
196. Loh FH, Koa RC. Laparoscopic hysterectomy versus abdominal hysterectomy: A controlled study of clinical and functional outcomes. Singapore Med J 2002;43:403-7.
197. Long CY, Fang JH, Chen WC, Su JH, Hsu SC. Comparison of total laparoscopic hysterectomy and laparoscopically assisted vaginal hysterectomy. Gynecol Obstet Invest 2002;53:214-19.
198. Saini J, Kuczynski E, Gretz HF 3rd, Sills ES. Supracervical hysterectomy versus total abdominal hysterectomy: Perceived effects on sexual function. BMC Womens Health 2002;2:1.
199. Korpelainen JT, Kauhanen ML, Kemola H, Malinen U, Myllyla VV. Sexual dysfunction in stroke patients. Acta Neurol Scand 1998;98:400-5.
200. Sagud M, Hotujac LJ, Mihaljevic-Peles A, Jakovljevic M. Gender differences in depression. Coll Antropol 2002;26:149-57.
201. Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affective Dis 2002;70:125-32.
202. DeJudicibus MA, McCabe MP. Psychological factors and the sexuality of pregnant and postpartum women. J Sex Res 2002;39:94-103.
203. Parry BL, Newton RP. Chronobiological basis of female-specific mood disorders. Neuropsychopharmacology 2001;25:S102-8.
204. Parry BL. Sex hormones, circadian rhythms and depressive vulnerability. Depression 1995;3:43-8.
205. McEwen BS, Parsons B. Gonadal steroid action on the brain: Neurochemistry and neuropharmacology. Ann Rev Pharmacol Toxicol 1982;22:555-98.
206. Clayton AH. Female sexual dysfunction related to depression and antidepressant medications. Curr Womens Health Rep 2002;2:182-7.
207. Baldwin DS. Depression and sexual dysfunction. Br Med Bull 2001;57:81-99.
208. Clayton AH. Recognition and assessment of sexual dysfunction associated with depression. J Clin Psychiatry 2001;62(3 suppl):5-9.
209. Bartlik B, Kocsis JH, Legere R, Villaluz J, Kossoy A, Gelenberg AJ. Sexual dysfunction secondary to depressive disorders. J Gend Specif Med 1999;2: 52-60.
210. Zajecka J, Dunner DL, Gelenberg AJ, Hirschfeld RM, Kornstein SG, Ninan PT, Rush AJ, Thase ME, Trivedi MH, Arnow BA, Borian FE, Manber R, Keller MB. Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination. J Clin Psychiatry 2002;63:709-16.
211. Phillips RL Jr, Slaughter JR. Depression and sexual desire. Am Fam Physician 2000;62:782-6.
212. Baldwin RC. Prognosis of depression. Curr Opin Psychiatry 2000;13:81-5.
213. Zourkova A, Hadasova E. Relationship between CYP2D6 metabolic status and sexual dysfunction in paroxetine treatment. J Sex Marital Ther 2002; 28:451-61.
214. Hensley PL, Nurnberg HG. SSRI sexual dysfunction: A female perspective. J Sex Marital Ther 2002;28(1 suppl):143-53.
215. MacQueen G, Born L, Steiner M. The selective serotonin reuptake inhibitor sertraline: Its profile and use in psychiatric disorders. CNS Drug Rev 2001;7:1-24.
216. Balon R. The effect of antidepressants on human sexuality: Diagnosis and management. Primary Psy 1995;53:212-13.
217. Peuskens J, Sienaert P, DeHert M. Sexual dysfunction. the unspoken side effects of antipsychotics. Eur Psy 1998;13(1 suppl):23-30.
218. Nurnberg HG, Hensley PL. Selective phosphodiesterase type-5 inhibitor treatment of serotonergic reuptake inhibitor antidepressant-associated sexual dysfunction. a review of diagnosis, treatment, and relevance. CNS Spectr 2003;8:194-202.
219. Balon R. Emotional blunting, sexual dysfunction and SSRIs. Int J Neuropsychopharmacol 2002;5: 415-16.
220. Kanaly KA, Berman JR. Sexual side effects of SSRI medications: Potential treatment strategies for SSRI-induced female sexual dysfunction. Curr Womens Health Rep 2002;2:409-16.
221. Ekselius L, von Knorring L. Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care. J Clin Psychopharmacol 2001;21:154-60.
222. Montgomery SA, Baldwin DS, Riley A. Antidepressant medications: A review of the evidence for drug-induced sexual dysfunction. J Affect Disord 2002;69:119-40.
223. Hensley PL, Nurnberg HG. SSRI sexual dysfunction: A female perspective. J Sex Marital Ther 2002;28(1 suppl):143-53.
224. Thase ME. Long-term nature of depression. J Clin Psychiatry 1999;60(14 suppl):3-9.
225. Bobes J, Gonzalez MP, Bascaran MT, Clayton A, Garcia M, Rico-Villade Moros F, Banus S. Evaluating changes in sexual functioning in depressed patients: Sensitivity to change of the CSFG. J Sex Marital Ther 2002;28:93-103.
226. Clayton AH, McGarvey EL, Clavet GJ. The changes in Sexual Functioning Questionnaire (CSFQ). J Sex Marital Ther 1997;26:119-31.
227. Michelson D, Schmidt M, Lee J, Tepner R. Changes in sexual function during acute and six-month fluoxetine therapy: A prospective assessment. J Sex Marital Ther 2001;27:289-330.
228. Nappi RE, Verde JB, Polatti F, Genazzani AR, Zara C. Self-reported sexual symptoms in women attending menopause clinics. Gynecol Obstet Invest 2002;53:181-7.
229. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 1987.
230. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: The impact of fatigue and depression. J Neurol Sci 2002;205:51-8.
231. Zorzon M, Zivadinov R, Locatelli L, Stival B, Nasuelli D, Bratina A, Bosco A, Tommasi MA, Pozzi Mucelli RS, Ukmar M, Cazzato G. Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosis. Mult Scler 2003;9:108-10.
232. Salonia A, Briganti A, Montorsi P, Margonato A, Nappi RE, Buzzetti F, Zanni G, Rigatti P, Montorsi F. Sexual dysfunction in women with coronary artery disease. Int J Impot Res 2002;14:S80.
233. Rosen RC, Brown C, Heiman J, Leiblum S, Meston CM, Shabsigh R, Ferguson D, D'Agostino R Jr. The female sexual function index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
234. Beck A, Beamersderfer A. Assessment of depression: The depression inventory. Mod Probl Pharmacopsychiatry 1974;7:151-69.
235. Derogatis LR, Rosen RC, Leiblum S, Burnett A, Heiman J. The female sexual distress scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 2002;28:317-30.
236. Park K, Goldstein I, Andry C, Siroky M, Krane RJ, Azadzoi K. Vasculogenic female sexual dysfunction: The hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res 1997;9:27-37.
237. Morokoff P, Heiman J. Effects of erotic stimuli on sexually functional and dysfunctional women: Multiple measures before and after sex therapy. Behav Res Ther 1980;18:127-37.
238. Wincze JP, Hoon EF, Hoon PW. Physiological responsivity of normal and sexually dysfunctional women during erotic stimulus exposure. J Psychosom Res 1976;20:445-51.
239. Wincze JP, Hoon EF, Hoon PW. Multiple measures analysis of women experiencing low sexual arousal. Behav Res Ther 1978;16:43-9.
240. Palace EM, Gorzalka BB. The enhancing effects of anxiety on arousal in sexually dysfunctional and functional women. J Abnorm Psychol 1990;99: 403-11.
241. Palace EM. Modification of dysfunctional patterns of sexual response through autonomic arousal and false physiological feedback. J Consult Clin Psychol 1995;63:604-15.
242. Meston CM, Gorzalka BB. Differential effects of sympathetic activation on sexual arousal in sexually dysfunctional and functional women. J Abnorm Psychol 1996;105:582-91.
243. Wouda JC, Hartman PM, Bakker RM, Bakker IO, van de Wiel HBM, Weijmar Schultz WCM. Vaginal plethysmography in women with dyspareunia. J Sex Res 1998;5:141-7.
244. Laan E, van Driel E, van Lunsen RHW. Sexual responses of women with sexual arousal disorder to visual sexual stimuli (in Dutch). Tijdschr Seksuol 2003;27:1-13.
245. Rosen RC, Beck JG. Patterns of sexual arousal. New York: The Guilford Press; 1988.
246. Laan E, Everaerd W. Determinants of female sexual arousal: Psychophysiological theory and data. Annu Rev Sex Res 1995;6:32-76.
247. Maravilla KR, Heiman JR, Garland PA, Cao Y, Carter WO, Peterson BT, Weiskoff RM. Dynamic MR: Imaging of the sexual arousal response in women. J Sex Marit Ther 2003;29(1 suppl):71-6.
248. Laan E, van Lunsen R. Hormones and sexuality in postmenopausal women: A psychophysiological study. J Psychosom Obstet Gynecol 1997;18:126-33.
249. van Lunsen RHW, Laan E. Genital vascular responsiveness and sexual feelings in mid life women: Psychological, brain and genital imaging studies. Menopause 2004 (in press).